Dr. Shinichi Sato, M.D., Ph.D. is Professor of Dermatology at Nagasaki University Graduate School of Medicine in Japan.
He graduated from the University of Tokyo in 1989 and since then, he has been joining scleroderma clinics in both the University of Tokyo and Kanazawa University. He has been investigating clinical aspects and immunologic abnormalities associated with scleroderma. Because he was a Research Associate in the Department of Immunology, Duke University Medical Center between 1994-1997, and studied molecular and cellular immunology of B lymphocytes, he is now actively investigating B lymphocyte abnormalities in SSc and trying to develop a novel therapeutic strategy for B lymphocytes. In 2003, he received the award of the Japanese Society of Investigative Dermatology, regarding B lymphocyte abnormalities of scleroderma.
He is also an Investigator in Elucidation of Pathogenesis and Development of Disease-Modifying Therapy in Scleroderma held by Ministry of Health, Labour and Welfare of Japan.
Shinichi Sato, MD, PhD
Department of Dermatology
Nagasaki University Graduate School of Medicine, 1-7-1
Sakamoto Nagasaki 852-8501
Office Phone: 81-95-849-7331
B lymphocytes and systemic sclerosis. B cells may have more pathogenic roles in systemic sclerosis than had been appreciated. Collectively, B cells and B-cell-specific response regulators such as CD19/CD22 appear to be potential therapeutic targets of the disease. PubMed, Curr Opin Rheumatol. 2005 Nov;17(6):746-51. (Also see Causes of Scleroderma: B Cells and T Cells)
Japanese: What is Scleroderma? Brochure.This new PDF brochure was translated from the ISN English brochure by Yoko, medically edited by Dr. Shinichi Sato, and desktop published by Susanne Piché. (Also see ISN: Japanese Version) Posted 10-03-05.
Localized scleroderma is an autoimmune disorder. Many previous studies conclude that localized scleroderma involves autoimmune abnormalities and is one of the organ-specific autoimmune disorders targeting mainly skin, although the types of autoimmune abnormality are different from systemic sclerosis. PubMed, Rheumatology (Oxford). 2004 Nov 23. (Also see Types of Scleroderma: Localized, Morphea, Linear, and Dr. Shinichi Sato)
ISN Liaison to Medical Advisory Board
Medical Advisory Board Members
|Foster, C. Stephen||U.S.|
|Van den Hoogen, Frank*||Netherlands|
|* = Need ISN Profile Submitted|
Contact information updated, 07-11-06. SLE.
SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to: